Sarah L Dallas1, Yixia Xie2, Lora A Shiflett2, Yasuyoshi Ueki2. 1. Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri, 650 E. 25th Street, Kansas, MO, 64108, USA. dallass@umkc.edu. 2. Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri, 650 E. 25th Street, Kansas, MO, 64108, USA.
Abstract
PURPOSE: Transgenic Cre lines are a valuable tool for conditionally inactivating or activating genes to understand their function. Here, we provide an overview of Cre transgenic models used for studying gene function in bone cells and discuss their advantages and limitations, with particular emphasis on Cre lines used for studying osteocyte and osteoclast function. RECENT FINDINGS: Recent studies have shown that many bone cell-targeted Cre models are not as specific as originally thought. To ensure accurate data interpretation, it is important for investigators to test for unexpected recombination events due to transient expression of Cre recombinase during development or in precursor cells and to be aware of the potential for germ line recombination of targeted genes as well as the potential for unexpected phenotypes due to the Cre transgene. Although many of the bone-targeted Cre-deleter strains are imperfect and each model has its own limitations, their careful use will continue to provide key advances in our understanding of bone cell function in health and disease.
PURPOSE: Transgenic Cre lines are a valuable tool for conditionally inactivating or activating genes to understand their function. Here, we provide an overview of Cre transgenic models used for studying gene function in bone cells and discuss their advantages and limitations, with particular emphasis on Cre lines used for studying osteocyte and osteoclast function. RECENT FINDINGS: Recent studies have shown that many bone cell-targeted Cre models are not as specific as originally thought. To ensure accurate data interpretation, it is important for investigators to test for unexpected recombination events due to transient expression of Cre recombinase during development or in precursor cells and to be aware of the potential for germ line recombination of targeted genes as well as the potential for unexpected phenotypes due to the Cre transgene. Although many of the bone-targeted Cre-deleter strains are imperfect and each model has its own limitations, their careful use will continue to provide key advances in our understanding of bone cell function in health and disease.
Authors: Christa Maes; Tatsuya Kobayashi; Martin K Selig; Sophie Torrekens; Sanford I Roth; Susan Mackem; Geert Carmeliet; Henry M Kronenberg Journal: Dev Cell Date: 2010-08-17 Impact factor: 12.270
Authors: Nicoletta Bivi; Keith W Condon; Matthew R Allen; Nathan Farlow; Giovanni Passeri; Lucas R Brun; Yumie Rhee; Teresita Bellido; Lilian I Plotkin Journal: J Bone Miner Res Date: 2012-02 Impact factor: 6.741
Authors: Fei Liu; Henning W Woitge; Alen Braut; Mark S Kronenberg; Alexander C Lichtler; Mina Mina; Barbara E Kream Journal: Int J Dev Biol Date: 2004-09 Impact factor: 2.203
Authors: Mei Zhang; Shouhong Xuan; Mary L Bouxsein; Dietrich von Stechow; Nagako Akeno; Marie Claude Faugere; Hartmut Malluche; Guisheng Zhao; Clifford J Rosen; Argiris Efstratiadis; Thomas L Clemens Journal: J Biol Chem Date: 2002-09-04 Impact factor: 5.157
Authors: Meiling Zhu; Ben-Hua Sun; Katarzyna Saar; Christine Simpson; Nancy Troiano; Sarah L Dallas; LeAnn M Tiede-Lewis; Erin Nevius; João P Pereira; Robert S Weinstein; Steven M Tommasini; Karl L Insogna Journal: J Bone Miner Res Date: 2015-11-18 Impact factor: 6.741
Authors: Jinhu Xiong; Marilina Piemontese; Melda Onal; Josh Campbell; Joseph J Goellner; Vladimir Dusevich; Lynda Bonewald; Stavros C Manolagas; Charles A O'Brien Journal: PLoS One Date: 2015-09-22 Impact factor: 3.240
Authors: Christopher S Kovacs; Catherine Chaussain; Philip Osdoby; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker Journal: Nat Rev Endocrinol Date: 2021-05-04 Impact factor: 43.330
Authors: Gregory B Lowen; Katherine A Garrett; Stephanie N Moore-Lotridge; Sasidhar Uppuganti; Scott A Guelcher; Jonathan G Schoenecker; Jeffry S Nyman Journal: J Biomech Eng Date: 2022-05-01 Impact factor: 2.097
Authors: Daniel J Klionsky; Giulia Petroni; Ravi K Amaravadi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Ken Cadwell; Francesco Cecconi; Augustine M K Choi; Mary E Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Vojo Deretic; Ivan Dikic; Zvulun Elazar; Eeva-Liisa Eskelinen; Gian Maria Fimia; David A Gewirtz; Douglas R Green; Malene Hansen; Marja Jäättelä; Terje Johansen; Gábor Juhász; Vassiliki Karantza; Claudine Kraft; Guido Kroemer; Nicholas T Ktistakis; Sharad Kumar; Carlos Lopez-Otin; Kay F Macleod; Frank Madeo; Jennifer Martinez; Alicia Meléndez; Noboru Mizushima; Christian Münz; Josef M Penninger; Rushika M Perera; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Laura Santambrogio; Luca Scorrano; Hans-Uwe Simon; Anna Katharina Simon; Anne Simonsen; Alexandra Stolz; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Lorenzo Galluzzi; Federico Pietrocola Journal: EMBO J Date: 2021-08-30 Impact factor: 14.012
Authors: Christopher D Kegelman; Madhura P Nijsure; Yasaman Moharrer; Hope B Pearson; James H Dawahare; Kelsey M Jordan; Ling Qin; Joel D Boerckel Journal: J Bone Miner Res Date: 2020-10-07 Impact factor: 6.741